Litcius/Paper detail

Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment

Rita Rubin

2022JAMA56 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyIntensive care medicineInternal medicineInfectious disease (medical specialty)DiseaseOutbreakPancreatitis Pathology and TreatmentCOVID-19 Clinical Research Studies
Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment | Litcius